2015 Sublimation Byk Annual Report: Net profit of 140 million, up 68.73% YoY

On February 27,, Sebastobaik released its 2015 annual reportDuring the reporting period, the Company realized operating income of RMB101,010.24 million, down 24.84% YoY, and net profit attributable to shareholders of listed companies was RMB13,988.45 million, up 68.73% YoYDuring the reporting period, the company's operating income decreased year-on-year mainly due to the company's main business affected by market factors, product sales revenue decreasedIn addition, Ningxia Gray will no longer be included in the consolidated financial statements as of April 30, 2015 due to the transfer of the company's stake in the original controlling subsidiary Ningxia GrayNingxia Gray mainly produces and operates pesticide intermediates of double glyconine, in 2014 to achieve operating income of 13,514.88 million yuan, net profit of 911.71 million yuan (data audited); During the reporting period, the net profit attributable to shareholders of listed companies increased year-on-year mainly due to the increase in the current profits of the company's joint ventures, Qingdao Yibang and Caitong FundAmong them, the scale of financial management of Caitong Fund increased year-on-year, operating income and net profit increased year-on-year, Qingdao Yibang continued to strengthen the promotion of high-end products, the Group's customer share further improved, operating income, net profit increased year-on-yeartuq
The main business sub-industry, sub-product, sub-region situation descriptiontuqpesticide products: during the reporting period, the company's main pesticide products wheat grass fear by market factors, industry competition intensified, product sales revenue decreased;tuq
Veterinary products: during the reporting period, the company's main productS L-tryptophan mainly affected by the bulk protein feed raw material stoume price downturn, L-tryptophan series prices continued to fall, resulting in a decline in veterinary drug product sales revenue of 12.03 percent year-on-yearFaced with many adverse situation, the company actively promote technological innovation, optimize the production process, reduce production costs, the reporting period of veterinary products gross margin increased by 5.49 percentage points over the same period last yeartuq
The product series: due to serious overcapacity and weak market demand, the reporting period of the series of products continued the previous year's downturn, the sales revenue of the series of products decreased by 10.73 percent year-on-yeartuq
During the reporting period, the year-on-year decline in the operating income of domestic companies was mainly due to the decline in domestic sales revenue due to the decline in domestic sales revenue due to the decline in domestic sales revenue due to the decline in the company's wheat grass, L-tryptophan and tantalum productstuq
Production and sales oftuq(1) reporting period L-tryptophan production and sales reduction, inventory increase year-on-year mainly affected by the bulk protein feed raw materials soybean meal price downturn, L-tryptophan prices continue to fall, quality prices have fallen below historical lows, premix prices and products keep pace with the downward trend, the company actively expand marketing ideas, increase product marketing efforts, L-tryptophan mixed agent market recognition of l-taffintuq
(2) Sulfuric acid mucosin by overcapacity, product homogenization competition intensified, the company followed the "to sell fixed production" mode of production and operation, to adopt an active sales strategy, increase product sales efforts, sulfate viscosin production decreased, inventory reductiontuq
(3) Reduction in sales of wheat grass: due to market factors, wheat grass fear industry competition intensified, product sales decreased, inventory increased tuq
　　(4) Increased sales of sain mycin: during the reporting period, due to the domestic counterpart sain mycomycin production enterprises stop production led to changes in the supply and demand relationship of products, short-term shortage of sain mycomycin supply, the company seized market opportunities to actively explore the market, during the reporting period, the sales volume of sainmycin increased year-on-year tuq
　　(5) Sales of oxychloride decreased: due to serious overcapacity, slow global economic recovery, weak market demand, the reporting period of the main products of the series of oxychloride continued the previous year's downturn, the company followed the "to sell fixed production" production and operation model, oxygen chloride tantalum sales, inventory decreased year-on-year tuq
　　(6) Acetyl acetone, methyl thiopental tin sales increase: the main company in order to make full use of production capacity, increase market development efforts, the main customers to adopt flexible sales policies, to the company acetyl acetone and series of products production and sales increased year-on-year, inventory decreased year-on-year tuq
　　On February 27th, Ascendas Byk released its 2015 annual report During the reporting period, the Company realized operating income of RMB101,010.24 million, down 24.84% YoY, and net profit attributable to shareholders of listed companies was RMB13,988.45 million, up 68.73% YoY During the reporting period, the company's operating income decreased year-on-year mainly due to the company's main business affected by market factors, product sales revenue decreased In addition, Ningxia Gray will no longer be included in the consolidated financial statements as of April 30, 2015 due to the transfer of the company's stake in the original controlling subsidiary Ningxia Gray Ningxia Gray mainly produces and operates pesticide intermediates of double glyconine, in 2014 to achieve operating income of 13,514.88 million yuan, net profit of 911.71 million yuan (data audited); During the reporting period, the net profit attributable to shareholders of listed companies increased year-on-year mainly due to the increase in the current profits of the company's joint ventures, Qingdao Yibang and Caitong Fund Among them, the scale of financial management of Caitong Fund increased year-on-year, operating income and net profit increased year-on-year, Qingdao Yibang continued to strengthen the promotion of high-end products, the Group's customer share further improved, operating income, net profit increased year-on-year tuq
　　The main business sub-industry, sub-product, sub-region situation description tuq pesticide products: during the reporting period, the company's main pesticide products wheat grass fear by market factors, industry competition intensified, product sales revenue decreased; tuq
　　Veterinary products: during the reporting period, the company's main productS L-tryptophan mainly affected by the bulk protein feed raw material stoume price downturn, L-tryptophan series prices continued to fall, resulting in a decline in veterinary drug product sales revenue of 12.03 percent year-on-year Faced with many adverse situation, the company actively promote technological innovation, optimize the production process, reduce production costs, the reporting period of veterinary products gross margin increased by 5.49 percentage points over the same period last year tuq
　　The product series: due to serious overcapacity and weak market demand, the reporting period of the series of products continued the previous year's downturn, the sales revenue of the series of products decreased by 10.73 percent year-on-year tuq
　　During the reporting period, the year-on-year decline in the operating income of domestic companies was mainly due to the decline in domestic sales revenue due to the decline in domestic sales revenue due to the decline in domestic sales revenue due to the decline in the company's wheat grass, L-tryptophan and tantalum products tuq
　　Production and sales of tuq (1) reporting period L-tryptophan production and sales reduction, inventory increase year-on-year mainly affected by the bulk protein feed raw materials soybean meal price downturn, L-tryptophan prices continue to fall, quality prices have fallen below historical lows, premix prices and products keep pace with the downward trend, the company actively expand marketing ideas, increase product marketing efforts, L-tryptophan mixed agent market recognition of l-taffin tuq
　　(2) Sulfuric acid mucosin by overcapacity, product homogenization competition intensified, the company followed the "to sell fixed production" mode of production and operation, to adopt an active sales strategy, increase product sales efforts, sulfate viscosin production decreased, inventory reduction tuq
　　(3) Reduction in sales of wheat grass: due to market factors, wheat grass fear industry competition intensified, product sales decreased, inventory increased tuq
　　(4) Increased sales of sain mycin: during the reporting period, due to the domestic counterpart sain mycomycin production enterprises stop production led to changes in the supply and demand relationship of products, short-term shortage of sain mycomycin supply, the company seized market opportunities to actively explore the market, during the reporting period, the sales volume of sainmycin increased year-on-year tuq
　　(5) Sales of oxychloride decreased: due to serious overcapacity, slow global economic recovery, weak market demand, the reporting period of the main products of the series of oxychloride continued the previous year's downturn, the company followed the "to sell fixed production" production and operation model, oxygen chloride tantalum sales, inventory decreased year-on-year tuq
　　(6) Acetyl acetone, methyl thiopental tin sales increase: the main company in order to make full use of production capacity, increase market development efforts, the main customers to adopt flexible sales policies, to the company acetyl acetone and series of products production and sales increased year-on-year, inventory decreased year-on-year tuq
Share it on feed